| Design and synthesis of novel quinoline/chalcone/1, 2, 4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases AM Mohassab, HA Hassan, D Abdelhamid, AM Gouda, BGM Youssif, ... Bioorganic chemistry 106, 104510, 2021 | 71 | 2021 |
| Novel quinoline incorporating 1, 2, 4-triazole/oxime hybrids: synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations AM Mohassab, HA Hassan, D Abdelhamid, M Abdel-Aziz, KN Dalby, ... Bioorganic chemistry 75, 242-259, 2017 | 51 | 2017 |
| STAT3 transcription factor as target for anti-cancer therapy AM Mohassab, HA Hassan, D Abdelhamid, M Abdel-Aziz Pharmacological Reports 72, 1101-1124, 2020 | 50 | 2020 |
| NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth TS Kaoud, AM Mohassab, HA Hassan, C Yan, SX Van Ravenstein, ... European Journal of Medicinal Chemistry 186, 111885, 2020 | 32 | 2020 |
| New quinoline/1, 2, 4-triazole hybrids as dual inhibitors of COX-2/5-LOX and inflammatory cytokines: Design, synthesis, and docking study AM Mohassab, HA Hassan, D Abdelhamid, AM Gouda, HAM Gomaa, ... Journal of Molecular Structure 1244, 130948, 2021 | 19 | 2021 |
| HDAC as a cancer target: Various scaffolds based on HDAC inhibitors and an overview of their advances AM Abdelraheem, OM Aly, MFA Mohamed, AM Mohassab Octahedron Drug Research 5 (1), 22-50, 2024 | | 2024 |
| Design and synthesis of new quinoline-ester/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases AM Mohassab, HA Hassan, HA Abou-Zied, M Fujita, M Otsuka, ... Journal of Molecular Structure 1297, 136953, 2024 | | 2024 |
| Design, synthesis and biological evaluation of novel NSAIDs with improved gastrointestinal safety profile H Abd-Ellah, A Mohassab, M Shoman, E Beshr, H Hassan, D Abdelhamid, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018 | | 2018 |
